Argentina’s PCR Raises US$400 Million in Its First International Bond

Company News · Argentina

A First Step Into Global Markets

PCR, a Comodoro Rivadavia-based energy group active in oil, gas and wind, had never tapped international bond markets before. Its debut US$400 million placement marks a milestone for the company and a test of appetite for Argentine corporate risk.

Issued alongside its subsidiary Luz de Tres Picos, the deal was structured under New York law. That framework gives foreign investors the legal comfort they typically require.

Strong Demand Drives an Upsize

The company initially sought up to US$350 million but lifted the size to US$400 million as orders poured in. Demand reached close to US$1 billion, roughly two and a half times the final amount.

Buyers spanned institutional investors in the United States and Europe, alongside local support. The eight-year notes priced at a fixed 8.5% annual coupon.

What the Money Is For

PCR said the proceeds will refinance existing debt at both PCR and Luz de Tres Picos. The rest will fund investment projects across its energy portfolio.

Refinancing at a fixed long-term rate lets the company lock in costs and extend maturities. For a capital-intensive energy business, that stability matters.

The Argentine Read-Through

A heavily subscribed debut from an Argentine issuer signals thawing investor sentiment toward the country’s corporates. It follows a broader reopening of external financing for select Argentine names.

For investors, PCR’s 8.5% coupon captures both the opportunity and the risk premium still attached to Argentina. For the energy sector, it is fresh capital to fund growth as the country leans on Vaca Muerta and renewables.

Frequently Asked Questions

How much did PCR raise in its first international bond?

PCR raised US$400 million, up from an initial target of US$350 million, in its debut international bond issued with subsidiary Luz de Tres Picos.

What are the terms of the PCR bond?

The dollar notes were issued under New York law with an eight-year maturity and a fixed 8.5% annual coupon, drawing orders of close to US$1 billion.

What will PCR use the funds for?

The company will use the proceeds to refinance debt at PCR and Luz de Tres Picos and to fund investment projects in its energy business.